Active Ingredient
Capsacin 0.228mg
Ageranium Patch
FDA Label NDC 71955-100
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Entom Co., Ltd. for the product Ageranium Patch (NDC 71955-100). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, keep out of reach of children, directions, inactive ingredients, ageranium patch, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
External analgesic
Uses
For temporary relief of minor aches & pains of muscles & joints associated with:
- arthritis
- simple backace
- strains
- bruises
- sprains
Warnings
For external use only
Allergy alert: If prone to have an allergic reaction to Capsaicin, cunsult a doctor before use.
Do not use
- on wounds or damaged skin
- if you are allergic to any ingredients of this product
When using this product
- use only as directed
- avoid contact with the eyes, mucous membran, and rashes
- wrap the bandage not too tight
Stop use and ask a doctor if
- Rash, itching, or excessive skin irritation develops
- conditions worsen
- symptoms persist for more than 7 days
- symptoms clear up and occur again within a few days
If pregnant or breas-feeding
- ask a health professional before use.
Keep Out Of Reach Of Children
Keep out or reach of children
- If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Adults and children over 12 years of age
- clean and dry affected area
- remove patch from film
- remove patch slowly and gentle from the skin after at most 8 hours application
Children under 12 years of age:
consult a doctor
Inactive Ingredients
Zinc oxide, Polybutene
* Please review the disclaimer below.
